Roquefort Therapeutics (LSE:ROQ) Market Cap : £6.33 Mil (As of Jun. 10, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Roquefort Therapeutics's share price for the quarter that ended in Dec. 2023 was £0.0725. Roquefort Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 129.15 Mil. Therefore, Roquefort Therapeutics's market cap for the quarter that ended in Dec. 2023 was £9.36 Mil.

Roquefort Therapeutics's quarterly market cap increased from Dec. 2022 (£8.56 Mil) to Jun. 2023 (£8.72 Mil) and increased from Jun. 2023 (£8.72 Mil) to Dec. 2023 (£9.36 Mil).

Roquefort Therapeutics's annual market cap increased from Dec. 2021 (£7.55 Mil) to Dec. 2022 (£8.56 Mil) and increased from Dec. 2022 (£8.56 Mil) to Dec. 2023 (£9.36 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Roquefort Therapeutics's Enterprise Value for Today is £5.79 Mil.

Roquefort Therapeutics Market Cap Historical Data

The historical data trend for Roquefort Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Market Cap Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Market Cap

7.55

8.56

9.36

Roquefort Therapeutics Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23
Market Cap	2.29	6.20	8.56	8.72	9.36

Competitive Comparison of Roquefort Therapeutics's Market Cap

For the Biotechnology subindustry, Roquefort Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roquefort Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's Market Cap falls into.

Roquefort Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Roquefort Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	£0.0725	*	129.15
	=	£9.36

Roquefort Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	£0.0725	*	129.15
	=	£9.36

Roquefort Therapeutics (LSE:ROQ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Roquefort Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics (LSE:ROQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

ROQAF:USA

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines